PJ019

N/A

Report date: 2024/09/04 16:25:15

Base Information

Drug NamePJ019
Drug Alias NamePJ019PJ-019
ClassificationBiologics
Mechanisms of ActionAsparagine modulators
TargetsAsparagine
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChongqing Peg-Bio Biopharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Peg-Bio Biopharm Co Ltd
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A